ArticleVaccines2024

Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease.

Henhen Heryaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.